ArticleNanomaterials (Basel, Switzerland)2025
Enhancing the Morpho-Structural Stability of FAPbBr
Article in Nanomaterials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Despite the huge progress achieved in the optimization of perovskite solar cell (PSC) performance, stability remains a limiting factor for technological commercialization. Here, a study on the photovoltaic, structural and morphological stability of semi-transparent formamidinium lead bromide-based PSCs is presented. This work focuses on the positive role of 2D nanoscale layer passivation, induced by perovskite surface treatment with a mixture of iso-Pentylammonium chloride (ISO) and neo-Pentylammonium chloride (NEO). In situ X-ray diffraction (XRD) is applied in combination with atomic force microscopy (AFM), and the results are correlated to the devices' photovoltaic performances. The superior power conversion efficiency and overall stability of the ISO-NEO system is evidenced, as compared to the un-passivated device, under illumination in air. Furthermore, the role of the ISO-NEO treatments in increasing the morpho-structural stability is clarified as follows: a bulk effect resulting in a protective role against the loss in crystallinity of the perovskite 3D phase (observed only for the un-passivated device) and an interface effect, being the observed 2D phase crystallinity loss spatially localized at the interface with the 3D phase where a higher concentration of defects is expected. Importantly, the complete stability of the device is achieved with the passivated ISO-NEO-encapsulated device, allowing us to exclude the intrinsic degradation effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.